Research Output per year
Organization profile
Profile Information
he Pharmaceutical Policy and Practice Research Centre provides a platform to enhance quality and quantity of research outputs in a competitive research environment.
The CPPPR aspires to become a leading pharmacy practice research centre to promote high quality research outputs. Our long-term vision aims for a research focus and alignment of our plans with external policies, challenges, and opportunities.
The Centre is planning a one day pharmacy practice research symposium in the summer of 2019.
Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit
Telemedicine
Medicine & Life Sciences
Biosimilar Pharmaceuticals
Medicine & Life Sciences
Costs and Cost Analysis
Medicine & Life Sciences
Medicine
Chemical Compounds
New Zealand
Medicine & Life Sciences
Pharmacies
Medicine & Life Sciences
Delivery of Health Care
Medicine & Life Sciences
Pharmaceutical Preparations
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Andrew Adams
- Department of Pharmacy - Senior Lecturer
- Pharmaceutical Policy and Practice Centre
- School of Applied Sciences
Person: Academic
Adeola Adebisi
- Department of Pharmacy - Senior Lecturer in Pharmacy
- Pharmaceutical Policy and Practice Centre
- School of Applied Sciences
Person: Academic
Saima Afzal
- Department of Pharmacy - Senior Lecturer in Pharmacy Practice
- Pharmaceutical Policy and Practice Centre
- School of Applied Sciences
Person: Academic, Doctor of Philosophy
Research Output 2018 2019
Medicine Prices in Asia–Pacific Countries
Babar, Z-U-D., Hussain, R. & Hasan, S. S., 2019, Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance. Vogler, S. (ed.). 1st ed. Elsevier, p. 45-60 15 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
Medicine
Cost Savings
Central Nervous System Diseases
Hepatitis C
Costs and Cost Analysis
Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review
Babar, Z-U-D., Gammie, T., Seyfoddin, A., Hasan, S. S. & Curley, L. E., Mar 2019, In : Research in Social and Administrative Pharmacy. 15, 3, p. 231-243 13 p.Research output: Contribution to journal › Review article
Open Access
File
Systems Analysis
Medicine
Drug and Narcotic Control
Health
New Zealand
Access to High Cost Medicines: An Overview
Hasan, S. S., Lu, C. & Babar, Z-U-D., 2 Mar 2018, Equitable Access to High-Cost Pharmaceuticals. Elsevier, p. 1-10 10 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
Costs and Cost Analysis
Delivery of Health Care
Traditional Medicine
Health Expenditures
Developing Countries